Prevalence of Ear-Related Problems in Individuals Recovered From COVID-19

Overview

Journal Iran J Otorhinolaryngol

Publisher Mashhad University of Medical Sciences

Specialty Otorhinolaryngology

Date 2024 May 15

PMID 38745685

Authors

Ahmadreza Nazeri

Amir Majidpour

Ali Nazeri

Ali Kamrani

Hashir Aazh

Affiliations

Soon will be listed here.

Abstract

Introduction: The aim was to assess prevalence of tinnitus, hyperacusis, hearing and balance problems among patients recovered from COVID-19 infection. Self-reported ear and hearing symptoms were compared in three groups comprising: confirmed COVID-19, possible COVID-19, and non-COVID-19.

Materials And Methods: 1649 participants completed the survey in this cross-sectional study. The mean age was 34 years and 65% were female. Participants with confirmed and possible COVID-19 were asked if after their infection (compared to the past) they experienced hearing loss, ringing or whistling noises, fullness or blockage in their ears, loudness of the sounds that are normal to other people bother them more (an indication of hyperacusis), dizziness, giddiness, or imbalance.

Results: Among participants with confirmed COVID-19, 16% reported that compared to the past their hearing has decreased, 21.5% noticed tinnitus, 22.5% aural fullness, 26.1% hyperacusis and 17.3% balance problems. Regression models showed that compared to the non-COVID-19 group, participants with confirmed COVID-19 had odds ratios (ORs) of significantly greater than 1 in predicting presence of self-reported symptoms of hearing loss, tinnitus, aural fullness, hyperacusis and balance problems, OR=1.96 (=0.001), OR=1.63 (=0.003), OR=1.8 (<0.001), OR=2.2 (<0.001), and OR=2.99 (<0.001), respectively.

Conclusions: There seem to be higher prevalence of self-report symptoms of ear-related problems among individuals with confirmed COVID-19 infection compared to a non-COVID-19 group during the pandemic.

References

Stratton S . Population Research: Convenience Sampling Strategies. Prehosp Disaster Med. 2021; 36(4):373-374. DOI: 10.1017/S1049023X21000649. View

Ghafari M, Kadivar A, Katzourakis A . Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran. Lancet Infect Dis. 2021; 21(5):602-603. PMC: 7906708. DOI: 10.1016/S1473-3099(21)00053-0. View

Neri E, Miele V, Coppola F, Grassi R . Use of CT and artificial intelligence in suspected or COVID-19 positive patients: statement of the Italian Society of Medical and Interventional Radiology. Radiol Med. 2020; 125(5):505-508. PMC: 7189175. DOI: 10.1007/s11547-020-01197-9. View

Sousa F, Pinto Costa R, Xara S, Pinto A, Almeida E Sousa C . SARS-CoV-2 and hearing: An audiometric analysis of COVID-19 hospitalized patients. J Otol. 2021; 16(3):158-164. PMC: 7857034. DOI: 10.1016/j.joto.2021.01.005. View

Verma H, Shah J, Akhilesh K, Shukla B . Patients' perspective about speech, swallowing and hearing status post-SARS-CoV-2 (COVID-19) recovery: E-survey. Eur Arch Otorhinolaryngol. 2022; 279(5):2523-2532. PMC: 8776384. DOI: 10.1007/s00405-021-07217-2. View

Nazemipour M, Shakiba M, Mansournia M . Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran. Lancet Infect Dis. 2021; 21(5):603-604. PMC: 7906695. DOI: 10.1016/S1473-3099(21)00044-X. View

Aazh H, Danesh A, Moore B . Self-Reported Tinnitus Severity Prior to and During the COVID-19 Lockdown in the United Kingdom. J Am Acad Audiol. 2022; 32(9):562-566. DOI: 10.1055/s-0041-1731733. View

Yang P, Ma W, Zheng Y, Yang H, Lin H . A Systematic Review and Meta-Analysis on the Association between Hypertension and Tinnitus. Int J Hypertens. 2016; 2015:583493. PMC: 4735998. DOI: 10.1155/2015/583493. View

Khalagi K, Gharibzadeh S, Khalili D, Mansournia M, Mirab Samiee S, Aghamohamadi S . Prevalence of COVID-19 in Iran: results of the first survey of the Iranian COVID-19 Serological Surveillance programme. Clin Microbiol Infect. 2021; 27(11):1666-1671. PMC: 8226066. DOI: 10.1016/j.cmi.2021.06.002. View

10.

Jafari Z, Kolb B, Mohajerani M . Hearing Loss, Tinnitus, and Dizziness in COVID-19: A Systematic Review and Meta-Analysis. Can J Neurol Sci. 2021; 49(2):184-195. PMC: 8267343. DOI: 10.1017/cjn.2021.63. View

11.

Beeching N, Fletcher T, Beadsworth M . Covid-19: testing times. BMJ. 2020; 369:m1403. DOI: 10.1136/bmj.m1403. View

12.

Zhou S, Wang Y, Zhu T, Xia L . CT Features of Coronavirus Disease 2019 (COVID-19) Pneumonia in 62 Patients in Wuhan, China. AJR Am J Roentgenol. 2020; 214(6):1287-1294. DOI: 10.2214/AJR.20.22975. View

13.

Danno K, Cognet-Dementhon B, Thevenard G, Duru G, Allaert F, Bordet M . Management of the early symptoms of influenza-like illnesses and ear, nose and throat (ENT) disorders by pharmacists. Homeopathy. 2014; 103(4):239-49. DOI: 10.1016/j.homp.2014.04.001. View

14.

Almufarrij I, Munro K . One year on: an updated systematic review of SARS-CoV-2, COVID-19 and audio-vestibular symptoms. Int J Audiol. 2021; 60(12):935-945. DOI: 10.1080/14992027.2021.1896793. View

15.

Kim J, Lee S, Cha J, Son G, Kim D . Chronic kidney disease is associated with increased risk of sudden sensorineural hearing loss and Ménière's disease: a nationwide cohort study. Sci Rep. 2021; 11(1):20194. PMC: 8511089. DOI: 10.1038/s41598-021-99792-x. View

16.

Fioretti A, Natalini E, Triggianese G, Eibenstein R, Angelone A, Lauriello M . Impact of the COVID-19 Lockdown on Patients with Chronic Tinnitus-Preliminary Results. Audiol Res. 2022; 12(3):327-336. PMC: 9220770. DOI: 10.3390/audiolres12030034. View

17.

Newman C, Sandridge S, Jacobson G . Psychometric adequacy of the Tinnitus Handicap Inventory (THI) for evaluating treatment outcome. J Am Acad Audiol. 1998; 9(2):153-60. View

18.

Dillard L, Martinez R, Perez L, Fullerton A, Chadha S, McMahon C . Prevalence of aminoglycoside-induced hearing loss in drug-resistant tuberculosis patients: A systematic review. J Infect. 2021; 83(1):27-36. DOI: 10.1016/j.jinf.2021.05.010. View

19.

Czubak J, Stolarczyk K, Orzel A, Fraczek M, Zatonski T . Comparison of the clinical differences between COVID-19, SARS, influenza, and the common cold: A systematic literature review. Adv Clin Exp Med. 2021; 30(1):109-114. DOI: 10.17219/acem/129573. View

20.

Yang W, Sirajuddin A, Zhang X, Liu G, Teng Z, Zhao S . The role of imaging in 2019 novel coronavirus pneumonia (COVID-19). Eur Radiol. 2020; 30(9):4874-4882. PMC: 7156903. DOI: 10.1007/s00330-020-06827-4. View